ACE inhibitors reduce risk of pneumonia in elderly following stroke Clinical study 09 February 2013 Pages: 16 - 16
Anakinra effective for “small proportion” with NSAID-refractory ankylosing spondylitis Clinical study 09 February 2013 Pages: 16 - 16
Peginterferon-α-2a for HCV after liver transplantation Clinical study 09 February 2013 Pages: 16 - 16
Low-dose Hib CRM 197 conjugate vaccine immunogenic in infants Clinical study 09 February 2013 Pages: 18 - 18
ACVBP outdoes CHOP/radiotherapy in low-risk aggressive lymphoma Clinical study 09 February 2013 Pages: 19 - 19
CD4+ cell count-guided treatment an effective strategy Clinical study 09 February 2013 Pages: 20 - 20
Eptacog alfa controls critical bleeding following blunt trauma Media release 09 February 2013 Pages: 20 - 20
Pioglitazone improves HAART-induced metabolic syndrome Clinical study 09 February 2013 Pages: 20 - 20
Flexible-dose darifenacin busting through in overactive bladder Clinical study 09 February 2013 Pages: 21 - 21
Intranasal influenza vaccination in children protects > 35 year olds Clinical study 09 February 2013 Pages: 21 - 21
Individualised docetaxel provides less variable exposure than BSA Clinical study 09 February 2013 Pages: 22 - 22
Irbesartan, atenolol improve diastolic function in left ventricular hypertrophy Clinical study 09 February 2013 Pages: 22 - 22
Should aspirin, not warfarin, be used in intracranial artery stenosis? Clinical study 09 February 2013 Pages: 22 - 22
Corticosteroids attenuate efficacy of colchicine in recurrent pericarditis News item 09 February 2013 Pages: 23 - 23
US FDA urged to keep topical corticosteroids behind the counter Media release 09 February 2013 Pages: 23 - 23
Enrolment suspended in Clevelox phase III safety trials Media release 09 February 2013 Pages: 24 - 24
Miltefosine approved in Colombia for cutaneous, visceral leishmaniasis Media release 09 February 2013 Pages: 24 - 24
Risk of worsening renal function with nesiritide in HF patients Clinical study 09 February 2013 Pages: 24 - 24
Dalteparin sodium approved in Canada for venous thrombosis Media release 09 February 2013 Pages: 26 - 26
Monovalent Oral Polio Vaccine 1 licensed for use in global eradication strategy Media release 09 February 2013 Pages: 26 - 26
Ranpirnase granted orphan drug status in Australia for malignant mesothelioma Media release 09 February 2013 Pages: 26 - 26